![Median overall survival according to CA 19-9 serum level baseline level. | Download Scientific Diagram Median overall survival according to CA 19-9 serum level baseline level. | Download Scientific Diagram](https://www.researchgate.net/publication/240307282/figure/fig1/AS:216448275357696@1428616698105/Median-overall-survival-according-to-CA-19-9-serum-level-baseline-level.png)
Median overall survival according to CA 19-9 serum level baseline level. | Download Scientific Diagram
![Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-65720-8/MediaObjects/41598_2020_65720_Fig1_HTML.png)
Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports
![Periostin and CA242 as potential diagnostic serum biomarkers complementing CA19.9 in detecting pancreatic cancer - Dong - 2018 - Cancer Science - Wiley Online Library Periostin and CA242 as potential diagnostic serum biomarkers complementing CA19.9 in detecting pancreatic cancer - Dong - 2018 - Cancer Science - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/198f4d6e-3e0f-40b8-a743-bfa30908a0fb/cas13712-fig-0001-m.jpg)
Periostin and CA242 as potential diagnostic serum biomarkers complementing CA19.9 in detecting pancreatic cancer - Dong - 2018 - Cancer Science - Wiley Online Library
![The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology](https://cdn.amegroups.cn/journals/pbpc/files/journals/1/articles/181/public/181-PB15-4535-R1.png/w300)
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology
![Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer | British Journal of Cancer Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fbjc.2011.453/MediaObjects/41416_2011_Article_BFbjc2011453_Fig1_HTML.jpg)
Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer | British Journal of Cancer
![Serum levels of hematopoietic cytokines and tumor markers in pancreatic... | Download Scientific Diagram Serum levels of hematopoietic cytokines and tumor markers in pancreatic... | Download Scientific Diagram](https://www.researchgate.net/publication/6559102/figure/tbl1/AS:786298558230530@1564479593763/Serum-levels-of-hematopoietic-cytokines-and-tumor-markers-in-pancreatic-cancer-patients.png)
Serum levels of hematopoietic cytokines and tumor markers in pancreatic... | Download Scientific Diagram
![Medicina | Free Full-Text | Fibrinogen-like Protein 1 as a Predictive Marker for the Incidence of Severe Acute Pancreatitis and Infectious Pancreatic Necrosis Medicina | Free Full-Text | Fibrinogen-like Protein 1 as a Predictive Marker for the Incidence of Severe Acute Pancreatitis and Infectious Pancreatic Necrosis](https://www.mdpi.com/medicina/medicina-58-01753/article_deploy/html/images/medicina-58-01753-g001.png)
Medicina | Free Full-Text | Fibrinogen-like Protein 1 as a Predictive Marker for the Incidence of Severe Acute Pancreatitis and Infectious Pancreatic Necrosis
![Combining CRP and CA19-9 in a novel prognostic score in pancreatic ductal adenocarcinoma | Scientific Reports Combining CRP and CA19-9 in a novel prognostic score in pancreatic ductal adenocarcinoma | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-80778-0/MediaObjects/41598_2020_80778_Fig1_HTML.png)
Combining CRP and CA19-9 in a novel prognostic score in pancreatic ductal adenocarcinoma | Scientific Reports
![Blood levels of adiponectin and IL-1Ra distinguish type 3c from type 2 diabetes: Implications for earlier pancreatic cancer detection in new-onset diabetes - eBioMedicine Blood levels of adiponectin and IL-1Ra distinguish type 3c from type 2 diabetes: Implications for earlier pancreatic cancer detection in new-onset diabetes - eBioMedicine](https://www.thelancet.com/cms/attachment/9051cbb2-7498-4c91-acab-5fe9befa4cb6/gr1.jpg)
Blood levels of adiponectin and IL-1Ra distinguish type 3c from type 2 diabetes: Implications for earlier pancreatic cancer detection in new-onset diabetes - eBioMedicine
![Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis - eBioMedicine Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis - eBioMedicine](https://www.thelancet.com/cms/attachment/c7b479be-8950-4e26-a29e-c817465360b1/gr1_lrg.jpg)
Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis - eBioMedicine
Serological characteristics of autoimmune pancreatitis and its differential diagnosis from pancreatic cancer by using a combination of carbohydrate antigen 19-9, globulin, eosinophils and hemoglobin | PLOS ONE
![Usefulness of CA 19–9 for pancreatic cancer screening in patients with new-onset diabetes - ScienceDirect Usefulness of CA 19–9 for pancreatic cancer screening in patients with new-onset diabetes - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1499387218300900-gr4.jpg)
Usefulness of CA 19–9 for pancreatic cancer screening in patients with new-onset diabetes - ScienceDirect
![Frontiers | Value of Carbohydrate Antigen 19-9 in Predicting Response and Therapy Control in Patients with Metastatic Pancreatic Cancer Undergoing First-Line Therapy Frontiers | Value of Carbohydrate Antigen 19-9 in Predicting Response and Therapy Control in Patients with Metastatic Pancreatic Cancer Undergoing First-Line Therapy](https://www.frontiersin.org/files/Articles/52319/fonc-03-00155-HTML/image_m/fonc-03-00155-g002.jpg)